Risk of preterm birth following treatment for cervical disease
8 August 2017
The meeting was held at the Wolfson Institute of Preventive Medicine on 16th February and it was aimed at colposcopists, gynaecologists, obstetricians and policy makers with an interest in cervical disease and/or preterm delivery.
The aims of this one day meeting were to review the available evidence on the risk of preterm birth following treatment for cervical disease, discuss the impact of this research on colposcopy and obstetric services and the next steps in making this evidence part of the national guidance.
Please follow the links below for the materials and programme of the meeting:
Please follow the links below for the materials and programme of the meeting:
- Programme [PDF 36KB]
- Similar results (preterm birth and treatment for CIN) from other publications (Kyrgiou) [PDF 1,015KB]
- Results from the PaCT cohort study BMJ 2012 (Sasieni) [PDF 986KB]
- Results from the PaCT case-control BMJ 2014 (Castanon) [PDF 542KB]
- Risk of preterm birth by number of births following colposcopy (Landy) [PDF 499KB]
- What excisions are we doing and why (Kitchener) [PDF 616KB]
- Impact of preterm birth on childhood outcomes (Quigley) [PDF 1,010KB]
- Is the risk of preterm completely mediated by cervical lenght (Poon) [PDF 494KB]